Preprint / Version 1

Molecular Mechanism of Coronaviruses (COVID-19) and Diagnostic Approaches

A Systematic Review

Authors

  • Lalit Mohan Jeena Department of Gynaecology and obstructive, IVF Centre, Maulana Azad Medical College https://orcid.org/0000-0001-6532-8814
  • Nidhi Singh Department of Gynaecology and obstructive, IVF Centre, Maulana Azad Medical College
  • Anjali Tempe Department of Gynaecology and obstructive, IVF Centre, Maulana Azad Medical College

DOI:

https://doi.org/10.21467/preprints.79

Abstract

An acute respiratory disease is rampantly spreading in population worldwide caused by a novel coronavirus (SARS-CoV-2, also known as COVID-19). The COVID-19 is a major source of disaster in the 21thcentury. It has spread throughout China and is received as a pandemic worldwide. To date (18th May 2020), a total of 4,827,272patients are infected and more than 3,17,174confirmed deaths have been reported with 6.57% fatality rate. Several research investigations have identified that COVID-19 belongs to ?-coronavirus family and has a highly identical genomic structure to bat coronavirus. The novel coronavirus uses the same receptor, ACE-2 (angiotensin-converting enzyme 2) as that for SARS-CoV, and mainly spreads through the respiratory tract. As per WHO, symptoms include shortness of breath especially in the lower respiratory tract, sore, throat, cough, headaches, and fever. However, the specific drugs required to prevent/treat an attack is a major need at this current point of time. In this regard, we conducted a systematic review on coronavirus to cover the molecular mechanism of viral entry and replication, which provides the basis of future management of COVID-19.

Keywords:

Novel coronavirus COVID-19, ACE-2, glycosylated protein and endocytosis

Downloads

References

(1). Sexton NR, Smith EC, Blanc H, Vignuzzi M, Peersen OB, Denison MR. Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens.JVirol. 2016;90(16):7415–7428. Published 2016 Jul 27. doi:10.1128/JVI.00080-16.

(2). de Groot RJ, Baker SC, Baric RS, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.JVirol. 2013;87(14):7790–7792. doi:10.1128/JVI.01244-13.

(3). Zhiqi S et al. From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses.2019 Jan;11(1): 59.doi: 10.3390/v11010059.

(4). Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect 2020;195-6701.

(5). McIntosh K, Arber W, Haas R, Henle W, Hofschneider PH, Jerne NK, Koldovský P, Koprowski H, Maaløe O, Rott R. "Coronaviruses: A Comparative Review". Current Topics in Microbiology and Immunology / Ergebnisse der Mikrobiologie und Immunitätsforschung. Berlin, Heidelberg: Springer 1974;87-119.

(6). Geller C, Varbanov M, Duval RE. Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies. Viruses 2012;4(11):3044-68.

(7). Guo Y, Cao Q, Hong Z. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Military Med Res 7,11:2020. https://doi.org/10.1186/s40779-020-00240-0.

(8). Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;22-28 February; 395(10224): 565–574.

(9). Fehr AR, Perlman S. Maier HJ, Bickerton E, Britton P (eds.). Coronaviruses: an overview of their replication and pathogenesis. Methods in Molecular Biology. Springer Science & Business Media New York 2015;1282:1-23.

(10). De GRJ, Baker SC, Baric R, et al. Family Coronaviridae, In King AM, Lefkowitz E, Adams MJ, Carstens EB, International Committee on Taxonomy of Viruses, International Union of Microbiological Societies 2011. Virology Division (eds.). Ninth Report of the International Committee on Taxonomy of Viruses. Oxford: Elsevier. pp. 806-28.

(11). Covid-19 coronavirus pandemic. 18th May 2020. https://www.worldometers.info/coronavirus/cuntries.

(12). Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med 2020;382(8):727–33.

(13). Lai MM, Cavanagh D. The molecular biology of coronaviruses. Advances in Virus Research 1997;48:1-100.

(14). International Committee on Taxonomy of Viruses. ICTV Master Species List 2009-v10;2010-08-24.

(15). Saberi A, Gulyaeva AA, Brubacher JL, Newmark PA, Gorbalenya AE. A planarian nidovirus expands the limits of RNA genome size. PLoSPathog 2018; 14(11): e1007314

(16). McBride R, Van ZM, Fielding BC. The coronavirus nucleocapsid is a multifunctional protein 2014;Aug7:6(8):2991-3018.

(17). Millet JK, Whittaker GR.Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res. 2015;16: 202:120-34.

(18). Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. doi:10.1038/nature02145.

(19). Mou H, Raj VS, van Kuppeveld FJ, Rottier PJ, Haagmans BL, Bosch BJ. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol. 2013;87(16):9379-83.

(20). Xiao X, Chakraborti S, Dimitrov AS, Gramatikoff K, Dimitrov DS. The SARS-CoV S glycoprotein: Expression and functional characterization. Biochem. Biophys. Res. Commun. 2003; 312:1159-1164.

(21). Bosch BJ, Bartelink W, Rottier PJ, Cathepsin L. functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. J Virol Sep 2008;82 (17):8887-8890.

(22). Armstrong J, Niemann H, Smeekens S, Rottier P, Warren G. Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus. Nature. 1984;308(5961):751–752. doi:10.1038/308751a0.

(23). Nal B, Chan C, KienF,etal.Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol 2005;86(5):1423-1434.

(24). Godet M, L'Haridon R, Vautherot JF, Laude H. TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions. Virology 1992;188(2):666-75.

(25). DeDiego ML, Alvarez E, Almazán F, Rejas MT, Lamirande E, Roberts A, Shieh WJ, Zaki SR, Subbarao K, Enjuanes L. J Virol. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in-vitro and in-vivo. J Virolo2007;81(4):1701-13.

(26). Chang CK, Sue SC, Yu TH, Hsieh CM, Tsai CK, Chiang YC, Lee SJ, Hsiao HH, Wu WJ, Chang WL, Lin CH, Huang TH. Modular organization of SARS coronavirus nucleocapsid protein. J Biomed Sci 2006;13(1):59-72.

(27). Hurst KR, Koetzner CA, Masters PS. Identification of in-vivo interacting domains of the murine coronavirus nucleocapsid protein. J Virol 2009;83(14):7221-34.

(28). Hurst KR, Koetzner CA, Masters P. Characterization of a critical interaction between the coronavirus nucleocapsid protein and nonstructural protein 3 of the viral replicase-transcriptase complex. J Virol 2013;87(16):9159-72.

(29). Sturman LS, Holmes KV, Behnke Isolation of coronavirus envelope glycoproteins and J interaction with the viral nucleocapsid. J Virol 1980;33(1):449-62.

(30). Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M. COVID-2019: the role of the nsp2 and nsp3 in its pathogenesis. J Med Virol 2020;92: 584-588.

(31). Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020;13;367(6483):1260-1263.

(32). Tang X, Wu C, Li X, et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev. 2020;nwaa036. Published 2020 Mar 3. doi:10.1093/nsr/nwaa036

(33). Saberi A, Gulyaeva AA, Brubacher JL, Newmark PA, Gorbalenya AE. A planarian nidovirus expands the limits of RNA genome size. PLoSPathog 2018; 14(11): e1007314.

(34). Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, and Acton S (1 Sep 2000). A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9. Circulation Research 2000;87:e1–e9.

(35). Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 2020; 5;562-569.

(36). Song W, Gui M, Wang X, Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoSPathog 2018; 14(8):e1007236.

(37). Simmons G, Zmora P, Gierer S, Heurich A, Pöhlmann S. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Research 2013;100(3): 605-14.

(38). Sawicki SG, Sawicki DL. Coronavirus transcription: a perspective. Curr Top Microbiol Immunol 2005; 287:31-55.

(39). Hussain S, Pan J, Chen Y, et al. Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus. J Virol May 2005;79(9):5288-95.

(40). Masters, P.S. The molecular biology of coronaviruses. Adv. Virus Res 2006; 66:193-292.

(41). Bos EC, Luytjes W, van der Meulen HV, Koerten HK, Spaan WJ. The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus.Virology 1996;1:218(1):52-60.

(42). Siu YL, Teoh KT, Lo J, et al. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J Virol 2008 Nov;82(22):11318-11330.

(43). Boscarino JA, Logan HL, Lacny JJ, Gallagher TM.Envelope protein palmitoylations are crucial for murine coronavirus assembly.JVirol 2008;82(6):2989-99.

(44). Ye Y & Hogue BG. Role of the coronavirus E viroporin protein transmembrane domain in virus assembly. J Virol 2007Apr ;81(7):3597-3607.

(45). Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003 May;348(20):1967-1976.

(46). Gorbalenya AE, Baker SC, Baric RS et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5:536-544.

(47). Saey TH. Story one: Scientists race to understand deadly new virus: SARS-like infection causes severe illness, but may not spread quickly among people. Science News 2013;183(6):5-6.

(48). Middle East respiratory syndrome coronavirus (MERS-CoV). www.who.int. Retrieved 15 April 2020. https://www.who.int/csr/don/08-april-2020-mers-saudi-arabia/en/

(49). Neeltje VD, Trenton B, Dylan H, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020; 382:1564-1567.

(50). Leibowitz JL. Coronaviruses: Molecular and Cellular Biology. Emerg Infect Dis. 2008;14(4):693–694. doi:10.3201/eid1404.080016

(51). Wong ACP, Li X, Lau Susanna KP, Woo Patrick CY. Global Epidemiology of Bat Coronaviruses. Viruses2019;11(2):174.

(52). Li F. Receptor recognition and cross-species infections of SARS coronavirus. Antiviral research. 2013 Oct;100(1):246-254.

(53). Remembering SARS: A Deadly Puzzle and the Efforts to Solve It. Centers for Disease Control and Prevention. Archived from the original on 2013. Retrieved 2013-08-03. https://www.cdc.gov/about/history/sars/feature.htm

(54). Coronavirus never before seen in humans is the cause of SARS. United Nations World Health Organization. Archived from the original on 2004-08-12. Retrieved 2006-07-05. https://news.un.org/en/story/2003/04/64992-who-announces-discovery-virus-causes-sars.

(55). Woo PC, Lau SK, Chu CM, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol. 2005 Jan;79(2):884-895.

(56). Vander HL, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med. 2004 Apr;10(4):368-373.

(57). Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Treatment of SARS with human interferons. Lancet. 2003 Jul;362(9380):293-4.

(58). Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects.PLoS Med.2006;3:e343.

(59). Laude H, Van Reeth K, Pensaert M. Porcine respiratory coronavirus: molecular features and virus-host interactions.Vet Res1993;24(2):125-150.

(60). Saif LJ. Animal coronavirus vaccines: lessons for SARS.Dev Biol (Basel)2004;119:129-140.

(61). He H Y, Tang X, Qin W, Xu Y, Wang X, Liu X, Liu S, Xiong J, Li MZ, Duan M. Construction of a eukaryotic expressionplasmidencoding partial S gene fragments of the SARS-CoV and its potential utility as a DNA vaccine.DNA Cell Biol.2005 Aug;24(8):516-520.

(62). He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, Jiang S. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunitvaccine.Biochem. Biophys. Res. Commun.2004 Nov;324(2):773-781.

(63). Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases?.Lancet Infect Dis. 2003;3(11):722–727. doi:10.1016/s1473-3099(03)00806-5

(64). Al-Bari MAA. Targeting endosomal acidification by chloroquine analogs as apromoting strategy for the treatment of emerging viral disease. Pharamcol Res Prespect. 2017;5(1):e00293.

(65). EMA clarifies use of chloroquine and hydroxychloroquine for COVID-19; 2April 2020. https://laegemiddelstyrelsen.dk/en/news/2020/ema-clarifies-use-of-chloroquine-and-hydroxychloroquine-for-covid-19.

(66). Emery SL, Erdman DD, Bowen MD, et al. Real-time reverse transcription-polymerase chain reaction assay for SARS associated coronavirus.Emerg Infect Dis2004;10(2):311-316.

(67). Gaunt ER, Hardie A, Claas EC, et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method.J Clin Microbiol2010;48(8):2940-2947.

(68). Updated WHO recommendations for international traffic in relation to COVID-19 outbreak. 29 February 2020. https://www.who.int/news-room/articles-detail/updated-who-advice-for-international-traffic-in-relation-to-the-outbreak-of-the-novel-coronavirus-2019-ncov.

(69). J.S.M. Peiris, in Medical Microbiology (Eighteenth Edition), 2012. https://www.sciencedirect.com/topics/neuroscience/coronavirus.

(70). Johns Hopkins, University & Medicine. New cases of COVID-19 in world countries. 18th May 2020. https://coronavirus.jhu.edu/data/new-cases.

(71). Transmission electron microscopy imaging of SARS-CoV-2. Indian Journal of Medicine Research. March 2020, pp 241-243. DOI: 10.4103/ijmr.IJMR_577_20

Downloads

Posted

2020-05-21

Section

Coronavirus

Categories